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Abstract
Introduction: Pigmented villonodular synovitis is a disease which affects the synovial joints and
tendon sheaths. Although the exact aetiological factors are not known, we believe that recurrent
haemarthrosis has a role in the aetiology of this condition.
Case presentation: A 62-year-old Caucasian man presented with gradually worsening pain and
stiffness in his right knee. The patient was on anticoagulation therapy and had been treated for
recurrent episodes of spontaneous haemarthrosis of the knee. The International Normalized Ratio
on each occasion suggested poor control of the anticoagulation therapy. A diagnosis of pigmented
villonodular synovitis was made based on intra-operative findings and was further confirmed by a
histopathological examination.
Conclusion: This report is presented to highlight the unusual association of haemarthrosis and
pigmented villonodular synovitis.
Introduction
Pigmented villonodular synovitis (PVNS) is a disease of
unknown aetiology affecting the synovial joints. The aeti-
ology of PVNS remains controversial and a number of the-
ories have been postulated. Haemarthrosis has been
suggested as a possible aetiological factor. Only one
description of PVNS of the ankle in a patient on anticoag-
ulation therapy has been previously reported [1]; we
describe the second known case of PVNS of the knee joint
in a patient on anticoagulation therapy.
Case presentation
A 62-year-old Caucasian man had an uneventful total left
knee replacement five years prior to presentation. Two
years following the total knee replacement, the patient
was diagnosed with dilated cardiomyopathy and was
started on warfarin. Following this, he had recurrent epi-
sodes of sudden pain and swelling on his right knee. Dur-
ing each of these episodes, there was no history of trauma
and the patient was systemically well. Although his Inter-
national Normalized Ratio (INR) was high, his blood tests
for full blood count and C-reactive protein were within
the normal range. All of these episodes were in the initial
phase of his warfarin therapy and they ceased once his
INR was stabilized.
The condition of the patient's right knee gradually deteri-
orated. Clinically, the knee joint was diffusely swollen
and tender but stable. His active range of movement was
from neutral to 100 degrees of flexion and any further
flexion was painful. Radiographs of the knee showed
advanced arthritic changes and he was admitted for a total
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knee replacement. Intraoperatively, the synovium was
found to be hypertrophic and stained reddish orange and
the synovial fluid was reddish-orange in colour (Figure 1).
These appearances suggested a diagnosis of PVNS. A syn-
ovectomy was performed, which was then followed by a
total knee replacement. A synovial specimen was sent for
histopathological examination. The microscopic features
were consistent with a diagnosis of PVNS (Figure 2). The
postoperative period was uneventful and the patient was
asymptomatic after three years of follow-up treatment.
Discussion
PVNS typically occurs in adults in their third or fourth
decade of life, with a male-to-female ratio of 1.9 to 1.3.
Involvement is usually monoarticular [2]. The knee joint
is the most frequently affected site, followed by the fin-
gers, feet, ankles, hips, wrists and shoulders in a decreas-
ing order of frequency [2,3].
Since the first description of this condition by Jaffe et al. in
1941 [4], the aetiology of this benign tumour involving
the synovial membrane has remained unclear. Jaffe pro-
posed that a hypervascular cellular phase occurs after
trauma produc ing hyalinization and fibrosis [4]. Various
aetiologies including trauma [2], inflammation [3],
haemorrhage [5], neoplasia [6] and genetic factors [7]
have been suggested. Chronic recurrent microtrauma and
haemarthrosis have also been postulated [2].
It has also been postulated that PVNS in children arises
through a different mechanism to that in adults, and it is
also possible that not all lesions interpreted as PVNS share
the same mechanism [8].
There are very few cases of PVNS reported in patients on
anticoagulation therapy [1] and with a bleeding disorder
[9]. In our patient, the symptoms in the knee worsened
following these repeated episodes of haemarthrosis and
the INR on these occasions showed a poor control of his
anticoagulation therapy.
Conclusion
This case supports the argument of earlier reports [1,9]
that repeated haemarthrosis may have a role in the aetiol-
ogy of PVNS. We hope that this study will encourage the
reporting of similar cases to lead to a better understanding
of the aetiology of this condition.
Abbreviations
INR: International Normalized Ratio; PVNS: pigmented
villonodular synovitis.
Intra-operative photographs showing the reddish-orange  stained synovium (black arrow) Figure 1
Intra-operative photographs showing the reddish-
orange stained synovium (black arrow).
Photomicrograph showing the presence of haemosiderin  deposits, foamy histiocytes and giant cells confirming pig- mented villonodular synovitis (haematoxylin and eosin stain) Figure 2
Photomicrograph showing the presence of haemosi-
derin deposits, foamy histiocytes and giant cells con-
firming pigmented villonodular synovitis 
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